TapImmune to Present at Two Upcoming Investor Conferences

March 14, 2018

Responsive image

JACKSONVILLE, Fla., March 14, 2018 /PRNewswire/ — TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced that its President and CEO, Peter Hoang, will participate in a panel discussion and…

Category: Precious Metals